A technology acquired for 600,000 is amortised on a straight-line basis over 10 years, with no residual value. After 4 years of amortisation, the year-end review shows that a competitor will make the technology obsolete: the remaining useful life is now only 3 years. The impairment test performed under IAS 36 as a result of this indication shows no impairment loss. What is the charge for the year following the revision?
- Cost of the technology
- 600,000
- Original useful life
- 10
- Period already amortised
- 4
- Revised remaining useful life
- 3